Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Stock Advisor

Your next 5 stock picks, already researched. Just click.

Recently Viewed

Clear All

Goldline Pharmaceutical IPO

Listed Listed stocks

IPO Rating

Quality Score fund-quick-summary-circle

0/0

Growth Score fund-quick-summary-circle

0/0

Valuation Score fund-quick-summary-circle

0/0

Know more link icon

Goldline Pharmaceutical IPO Details

  • Bidding Date

    12-May-2026 to
    14-May-2026

  • Issue Size

    ₹11.61 Cr

  • Price Band

    ₹41 to ₹43

  • Allotment date

    15-May-2026

  • Listing date

    19-May-2026

  • Lot size

    3000

  • No. of shares

    27,00,000

  • Fresh issue/OFS

    ₹11.61 Cr /--

About Goldline Pharmaceutical Company

Goldline Pharmaceutical, founded in 1999, is an India-based pharmaceutical marketing company that has grown from a focused regional brand into a broader product-led business operating across multiple therapeutic and specialty segments. Its core activity is marketing medicines under the Goldline brand rather than manufacturing them in-house, working with third-party manufacturers and a distributor network to supply products to retailers, wholesalers, hospitals, and healthcare providers. The company’s portfolio spans several formulation categories and specialties, including physician, orthopedics, ENT, chest, surgery, gastroenterology, neurology, and urology segments, and it has expanded through brand extensions, new drug-delivery formats, and locally developed formulations. Its strengths include market-driven product selection, the ability to launch differentiated compositions, and a distribution model that supports steady access across multiple states, while its client engagement approach emphasizes responsiveness to practitioner demand, portfolio refreshment, and regulatory-compliant supply partnerships.

Subscription Status

  • Category

    Status

  • QIBs

    --

  • NIIs

    --

  • Retail

    --

  • Others

    --

  • Total

    --

Goldline Pharmaceutical Financials

ipo banner

Recent IPOs

Name Price Band (Rs) Bidding Date
Avience Biomedicals 196 - 208 18-Jun-2026 to 22-Jun-2026
Riyaasat Lifestyle 102 - 108 18-Jun-2026 to 22-Jun-2026
Liotech 321 17-Jun-2026 to 19-Jun-2026
Clay Craft India 193 - 203 17-Jun-2026 to 19-Jun-2026
IPO MonitorIPO Monitor

FAQs for Goldline Pharmaceutical IPO.

The issue size of Goldline Pharmaceutical is ₹11.61 Cr.

Goldline Pharmaceutical falls into Pharmaceuticals industry.

The Goldline Pharmaceutical IPO will be listed on NSE.

The open and close dates for the Goldline Pharmaceutical are 12-May-2026 & 14-May-2026.

The price band for the Goldline Pharmaceutical ipo is ₹41 to ₹43

The listing date of Goldline Pharmaceutical IPO is 19-May-2026.

The purpose of this IPO is to raise fresh capital.

Key financial of the Goldline Pharmaceutical are:


Goldline Pharmaceutical FY-25 FY-24 FY-23
Revenue (₹ Cr) 28.06 23.57 19.85
EBIT (₹ Cr) 5.81 4.14 2.03
Proft after Tax (₹ Cr) 2.83 1.81 0.26
Debt (₹ Cr) 11.03 11.13 10.83
Net Worth (₹ Cr) 10.35 7.87 5.89
RoE (%) 27.37 22.96 4.36

Home > IPO Monitor > Goldline Pharmaceutical